Non-alcoholic fatty liver disease risk factors: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
|||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of NAFLD is obesity. Other risk factors include insulin resistence and metabolic syndrome. | |||
==Risk Factors== | ==Risk Factors== | ||
*Medications like [[Tamoxifen]] ,[[corticosteriods]] , [[methotrexate]] | |||
*[[Viral Hepatitis]]. | |||
*Rapid weight loss. | |||
*Malnutrition. | |||
*High levels of triglyceride in blood. | |||
*Sleep apnea. | |||
*Hypothyroid. | |||
*Hypopituitarism . | |||
==References== | ==References== |
Revision as of 20:42, 11 December 2017
Non-Alcoholic Fatty Liver Disease Microchapters |
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case studies |
Non-alcoholic fatty liver disease risk factors On the Web |
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease risk factors |
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Risk calculators and risk factors for Non-alcoholic fatty liver disease risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
The most potent risk factor in the development of NAFLD is obesity. Other risk factors include insulin resistence and metabolic syndrome.
Risk Factors
- Medications like Tamoxifen ,corticosteriods , methotrexate
- Viral Hepatitis.
- Rapid weight loss.
- Malnutrition.
- High levels of triglyceride in blood.
- Sleep apnea.
- Hypothyroid.
- Hypopituitarism .